MC869A1 - Furanosyl-aminopurines et médicament contenant ces substances - Google Patents

Furanosyl-aminopurines et médicament contenant ces substances

Info

Publication number
MC869A1
MC869A1 MC923A MC923A MC869A1 MC 869 A1 MC869 A1 MC 869A1 MC 923 A MC923 A MC 923A MC 923 A MC923 A MC 923A MC 869 A1 MC869 A1 MC 869A1
Authority
MC
Monaco
Prior art keywords
aminopurines
furanosyl
substances
medicines containing
medicines
Prior art date
Application number
MC923A
Other languages
English (en)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of MC869A1 publication Critical patent/MC869A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
MC923A 1969-11-17 1970-11-10 Furanosyl-aminopurines et médicament contenant ces substances MC869A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87744369A 1969-11-17 1969-11-17

Publications (1)

Publication Number Publication Date
MC869A1 true MC869A1 (fr) 1971-09-28

Family

ID=25369972

Family Applications (1)

Application Number Title Priority Date Filing Date
MC923A MC869A1 (fr) 1969-11-17 1970-11-10 Furanosyl-aminopurines et médicament contenant ces substances

Country Status (26)

Country Link
US (1) US3666856A (fr)
JP (1) JPS5429520B1 (fr)
AT (1) AT309696B (fr)
BE (1) BE759011A (fr)
BR (1) BR6915136D0 (fr)
CA (1) CA967564A (fr)
CH (2) CH555344A (fr)
CS (1) CS181701B2 (fr)
DE (1) DE2056327C2 (fr)
DK (1) DK128117B (fr)
ES (2) ES385590A1 (fr)
FI (1) FI54315C (fr)
FR (1) FR2073364B1 (fr)
GB (2) GB1338906A (fr)
HU (1) HU163812B (fr)
IE (1) IE34737B1 (fr)
IL (1) IL35658A (fr)
LU (1) LU62071A1 (fr)
MC (1) MC869A1 (fr)
NL (1) NL171589C (fr)
NO (1) NO128156B (fr)
PL (1) PL81167B1 (fr)
SE (1) SE385374B (fr)
YU (2) YU35033B (fr)
ZA (1) ZA707722B (fr)
ZM (1) ZM12970A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081534A (en) * 1973-09-11 1978-03-28 Burroughs Wellcome Co. Amino purine nucleosides as autoimmune suppressant agents
GB1562899A (en) * 1975-06-17 1980-03-19 Wellcome Found Pharmaceutical compositions containing substituted 9-( -d-arabnofuranosyl)purine-5'-phosphate and salts thereof
US4210745A (en) * 1978-01-04 1980-07-01 The United States Of America As Represented By The Department Of Health, Education And Welfare Procedure for the preparation of 9-β-D-arabinofuranosyl-2-fluoroadenine
DE3319282A1 (de) * 1983-05-27 1984-11-29 Gödecke AG, 1000 Berlin Verwendung von adenosin bei der behandlung von herpes
GB8712745D0 (en) * 1987-05-30 1987-07-01 Wellcome Found Antiviral compounds
WO1989008658A1 (fr) * 1988-03-16 1989-09-21 Scripps Clinic And Research Foundation Derives d'adenine substitues utiles en tant qu'agents therapeutiques
IE882585L (en) * 1988-08-25 1990-02-25 Prendergast Patrick T Viral treatment system
US5292725A (en) * 1988-08-25 1994-03-08 Prendergast Patrick T Administering particular compounds against various parasites, mycoplasmas, other indications and other infections
US5681941A (en) * 1990-01-11 1997-10-28 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
US5308837A (en) * 1990-08-22 1994-05-03 Merrell Dow Pharmaceuticals Inc. 5'-amine substituted adenosine analogs as immunosuppressants
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
US6232463B1 (en) 1997-10-09 2001-05-15 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
WO1999057120A1 (fr) 1998-05-04 1999-11-11 Neotherapeutics, Inc. Nouvelle hypoxanthine 9-substituee apparentee a la serotonine
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
AU2001271908A1 (en) 2000-07-07 2002-01-21 Neotherapeutics, Inc. Methods for treatment of disease-induced peripheral neuropathy and related conditions
US6759427B2 (en) * 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
CN105237602B (zh) * 2015-06-25 2018-05-18 新乡学院 一种2-氨基阿糖腺苷的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3208997A (en) * 1962-11-15 1965-09-28 Sankyo Co Process for preparing purine and pyrimidine nucleosides
US3407191A (en) * 1966-08-29 1968-10-22 Lilly Co Eli Adamantoate esters of nucleosides
JPH1097965A (ja) * 1996-09-20 1998-04-14 Sony Corp 生産管理方法

Also Published As

Publication number Publication date
IE34737B1 (en) 1975-08-06
CS181701B2 (en) 1978-03-31
DE2056327C2 (de) 1984-10-11
ES413787A1 (es) 1976-01-16
GB1338905A (en) 1973-11-28
SE385374B (sv) 1976-06-28
FI54315B (fi) 1978-07-31
IL35658A0 (en) 1971-01-28
ZA707722B (en) 1972-06-28
NL171589B (nl) 1982-11-16
CH555344A (de) 1974-10-31
BR6915136D0 (pt) 1973-04-19
LU62071A1 (fr) 1971-08-12
JPS5429520B1 (fr) 1979-09-25
YU35033B (en) 1980-06-30
ES385590A1 (es) 1973-10-01
US3666856A (en) 1972-05-30
YU35034B (en) 1980-06-30
NO128156B (fr) 1973-10-08
FI54315C (fi) 1978-11-10
DE2056327A1 (de) 1971-06-03
YU280670A (en) 1979-12-31
FR2073364B1 (fr) 1974-03-22
HU163812B (fr) 1973-10-27
GB1338906A (en) 1973-11-28
IE34737L (en) 1971-05-17
AT309696B (de) 1973-08-27
IL35658A (en) 1974-10-22
CH555833A (de) 1974-11-15
DK128117B (da) 1974-03-04
YU201978A (en) 1979-12-31
NL171589C (nl) 1983-04-18
FR2073364A1 (fr) 1971-10-01
ZM12970A1 (en) 1972-07-21
CA967564A (en) 1975-05-13
BE759011A (fr) 1971-05-17
NL7016766A (fr) 1971-05-19
PL81167B1 (fr) 1975-08-30

Similar Documents

Publication Publication Date Title
MC869A1 (fr) Furanosyl-aminopurines et médicament contenant ces substances
BE766589A (fr) Composition et produit photosensibles et thermodeveloppables
BE787103A (fr) Nouveaux derives de propanolamine et composition pharmaceutiqueles contenant
BE746656A (fr) 5-pyridyl-2-imidazolones et medicaments contenant ces composes
BR6915289D0 (pt) Composicao inativante contendo etiletilenimina
BE756378A (fr) Composition et produit photosensibles contenant des photo-oxydants
FR7616M (fr) Nouveaux medicaments benzeniques et compositions les contenant
BE749864A (fr) Nouvelle composition pharmaceutique effervescente
AT323314B (de) Mischkapsel und zugehörige ausbringvorrichtung
BE754588A (fr) Thiophene-sulfonyl-urees et les medicaments qui contiennent cessubstances
BE747086A (fr) Derive azepinique et medicaments contenant un tel derive
CH531349A (de) Flüssiges Haarwaschmittel
BE756627A (fr) Emulsions positives directes contenant des amino-boranes et dessels de bismuth
FR2281766A1 (fr) Oestratetraenes et medicament contenant ces substances
FR3207M (fr) Nouvelles substances médicamenteuses et compositions les contenant.
BE760328A (fr) Nouvelle association medicamenteuse
BE746505A (fr) Benzene-sulfonyl-uree et sa preparation
BE756973A (fr) Hydroxyphenyl-2-piperidinylcarbinols et compositions pharmaceutiques encontenant
BE752360A (fr) Polymercapto-polyphosphites et polyphosphates
BE753857A (fr) Nouveaux medicaments normolipemiants
AT311719B (de) Akarizide und insektizide zusammensetzung
BE759692A (fr) Medicament mineralo-vegetal
ZA701904B (en) Medicinal substance
BR6915336D0 (pt) Reptidios contendo tirosina-o-sulfato
BE745022A (fr) Composition pharmaceutique